1,3-Dicaffeoylquinic Acid

• CAT Number: R025452
• CAS Number: 19870-46-3
• Molecular Formula: C25H24O12
• Molecular Weight: 516.45
• Purity: ≥95%
• Synonyms: 3,4-Dihydroxy-cinnamic Acid 1-Carboxy-4,5-dihydroxy-1,3-cyclohexylene Ester;?Cyclohexanecarboxylic Acid; (1S,3R,4R,5R)-1,3-Bis[[3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]oxy]-4,5-dihydroxy-cyclohexanecarboxylic Acid; [1S-(1α,3β,4α,5α)]-1,3-Bis[[3-(3,4
• Storage: 2-8°C
• IUPAC Name: (1S,3R,4R,5R)-1,3-bis[[(E)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy]-4,5-dihydroxycyclohexane-1-carboxylic acid
• InChI: InChI=1S/C25H24O12/c26-15-5-1-13(9-17(15)28)3-7-21(31)36-20-12-25(24(34)35,11-19(30)23(20)33)37-22(32)8-4-14-2-6-16(27)18(29)10-14/h1-10,19-20,23,26-30,33H,11-12H2,(H,34,35)/b7-3+,8-4+/t19-,20-,23-,25+/m1/s1
• InChIKey: YDDUMTOHNYZQPO-PSEXTPKNSA-N
• SMILES: C1C(C(C(CC1(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)O

1,3-caffeoylquinic acid（Cat No.:R025452） is a compound with potential therapeutic effects as an antihyperlipidemic drug. It has been studied for its ability to lower lipid levels in the body, thereby addressing hyperlipidemia, a risk factor for cardiovascular diseases. Additionally, it shows promise as a neuroprotectant against amyloid-β toxicity, a hallmark of Alzheimer’s disease. By mitigating the toxic effects of amyloid-β, 1,3-caffeoylquinic acid holds potential for the treatment of Alzheimer’s disease.